27 January 2021 - Deborah Wilkes
Premium
Hikma Pharmaceuticals has confirmed it is in discussions with GlaxoSmithKline (GSK) about the potential acquisition of certain pharmaceutical and consumer assets in Egypt and Tunisia.
New to OTCToolbox?
This is available as part of an Annual Subscription to the OTCToolbox website.